Carboplatin + Etoposide

Treatment for Tracheal, bronchus, and lung cancer

Typical Dosage: Carboplatin AUC 5-6 IV Day 1; Etoposide 100-120 mg/m2 IV Days 1-3, every 3 weeks

Effectiveness
55%
Safety Score
25%
Clinical Trials
500
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
Carboplatin AUC 5-6 IV Day 1; Etoposide 100-120 mg/m2 IV Days 1-3, every 3 weeks
Time to Effect
1-2 months
Treatment Duration
4-6 cycles (approx. 3-4 months)
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15,000
Monitoring:$5,000
Side Effect Mgmt:$10,000
Total Annual:$30,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$46,154
Cost per Remission
$300,000
Carboplatin + Etoposide Outcomes

for Tracheal, bronchus, and lung cancer

Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+65%
Remission Rate
+10%
Common Side Effects
Myelosuppression (Neutropenia, Thrombocytopenia, Anemia)
+90%
Nausea/Vomiting
+80%
Fatigue
+70%
Alopecia
+70%
Peripheral Neuropathy
+20%
Mucositis
+20%

Sources:

hep.com.cn
researchgate.net
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov